Kiora Pharmaceuticals Statistics
Total Valuation
KPRX has a market cap or net worth of $16.24 million. The enterprise value is -$269,141.
| Market Cap | 16.24M |
| Enterprise Value | -269,141 |
Important Dates
The next estimated earnings date is Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KPRX has 6.36 million shares outstanding. The number of shares has increased by 17.44% in one year.
| Current Share Class | 4.42M |
| Shares Outstanding | 6.36M |
| Shares Change (YoY) | +17.44% |
| Shares Change (QoQ) | +17.56% |
| Owned by Insiders (%) | 2.10% |
| Owned by Institutions (%) | 16.54% |
| Float | 3.85M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.97 |
| P/TBV Ratio | 0.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 8.97 |
| Quick Ratio | 8.33 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -489.62 |
Financial Efficiency
Return on equity (ROE) is -56.36% and return on invested capital (ROIC) is -2,482.70%.
| Return on Equity (ROE) | -56.36% |
| Return on Assets (ROA) | -21.92% |
| Return on Invested Capital (ROIC) | -2,482.70% |
| Return on Capital Employed (ROCE) | -45.66% |
| Weighted Average Cost of Capital (WACC) | 3.10% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$845,131 |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.29M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -9.84% in the last 52 weeks. The beta is -0.22, so KPRX's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | -9.84% |
| 50-Day Moving Average | 2.60 |
| 200-Day Moving Average | 2.39 |
| Relative Strength Index (RSI) | 45.71 |
| Average Volume (20 Days) | 13,677 |
Short Selling Information
The latest short interest is 4,019, so 0.06% of the outstanding shares have been sold short.
| Short Interest | 4,019 |
| Short Previous Month | 3,518 |
| Short % of Shares Out | 0.06% |
| Short % of Float | 0.10% |
| Short Ratio (days to cover) | 0.29 |
Income Statement
| Revenue | n/a |
| Gross Profit | -3.88M |
| Operating Income | -9.77M |
| Pretax Income | -12.28M |
| Net Income | -10.99M |
| EBITDA | -9.73M |
| EBIT | -9.77M |
| Earnings Per Share (EPS) | -$2.30 |
Balance Sheet
The company has $16.84 million in cash and $333,022 in debt, with a net cash position of $16.51 million or $2.59 per share.
| Cash & Cash Equivalents | 16.84M |
| Total Debt | 333,022 |
| Net Cash | 16.51M |
| Net Cash Per Share | $2.59 |
| Equity (Book Value) | 16.86M |
| Book Value Per Share | 2.65 |
| Working Capital | 18.89M |
Cash Flow
In the last 12 months, operating cash flow was -$8.51 million and capital expenditures -$107,068, giving a free cash flow of -$8.61 million.
| Operating Cash Flow | -8.51M |
| Capital Expenditures | -107,068 |
| Depreciation & Amortization | 42,364 |
| Net Borrowing | n/a |
| Free Cash Flow | -8.61M |
| FCF Per Share | -$1.35 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
KPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -17.44% |
| Shareholder Yield | -17.44% |
| Earnings Yield | -67.71% |
| FCF Yield | -53.09% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2024. It was a reverse split with a ratio of 1:9.
| Last Split Date | Jun 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:9 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |